Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4012 | 1790 | 35.4 | 55% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OPIAD | Author keyword | 3 | 100% | 0% | 3 |
2 | SECT CANC PAIN MANAGEMENT | Address | 3 | 100% | 0% | 3 |
3 | AGR FO TRY 310C | Address | 2 | 67% | 0% | 2 |
4 | IN VITRO LH SECRETION | Author keyword | 2 | 67% | 0% | 2 |
5 | OPIATE MODULATION | Author keyword | 2 | 67% | 0% | 2 |
6 | A1 NEURON | Author keyword | 1 | 100% | 0% | 2 |
7 | CYCLIC PIGS | Author keyword | 1 | 100% | 0% | 2 |
8 | HYPOTHALAMIC OVARIAN FAILURE | Author keyword | 1 | 100% | 0% | 2 |
9 | OPIOID RISK | Author keyword | 1 | 100% | 0% | 2 |
10 | PHARM MED POLO PONTINO | Address | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OPIAD | 3 | 100% | 0% | 3 | Search OPIAD | Search OPIAD |
2 | IN VITRO LH SECRETION | 2 | 67% | 0% | 2 | Search IN+VITRO+LH+SECRETION | Search IN+VITRO+LH+SECRETION |
3 | OPIATE MODULATION | 2 | 67% | 0% | 2 | Search OPIATE+MODULATION | Search OPIATE+MODULATION |
4 | A1 NEURON | 1 | 100% | 0% | 2 | Search A1+NEURON | Search A1+NEURON |
5 | CYCLIC PIGS | 1 | 100% | 0% | 2 | Search CYCLIC+PIGS | Search CYCLIC+PIGS |
6 | HYPOTHALAMIC OVARIAN FAILURE | 1 | 100% | 0% | 2 | Search HYPOTHALAMIC+OVARIAN+FAILURE | Search HYPOTHALAMIC+OVARIAN+FAILURE |
7 | OPIOID RISK | 1 | 100% | 0% | 2 | Search OPIOID+RISK | Search OPIOID+RISK |
8 | SHORT ACTING OPIOID | 1 | 100% | 0% | 2 | Search SHORT+ACTING+OPIOID | Search SHORT+ACTING+OPIOID |
9 | OPIOID PEPTIDE RECEPTORS | 1 | 40% | 0% | 2 | Search OPIOID+PEPTIDE+RECEPTORS | Search OPIOID+PEPTIDE+RECEPTORS |
10 | GONADOTROPIN RELEASING HORMONE PULSE GENERATOR | 1 | 33% | 0% | 2 | Search GONADOTROPIN+RELEASING+HORMONE+PULSE+GENERATOR | Search GONADOTROPIN+RELEASING+HORMONE+PULSE+GENERATOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENDOGENOUS OPIOID INFLUENCE | 14 | 100% | 0% | 7 |
2 | LH SECRETION | 13 | 13% | 5% | 91 |
3 | ENDOGENOUS OPIOID PEPTIDES | 11 | 22% | 2% | 44 |
4 | ENDOGENOUS OPIATES | 7 | 20% | 2% | 30 |
5 | ORAL OPIOIDS | 6 | 38% | 1% | 13 |
6 | NALOXONE REVERSIBLE INHIBITION | 6 | 71% | 0% | 5 |
7 | ENDOGENOUS OPIOID MODULATION | 6 | 50% | 1% | 9 |
8 | IMMATURE MALE PIG | 6 | 100% | 0% | 4 |
9 | MET ENKEPHALIN ANALOG | 5 | 60% | 0% | 6 |
10 | OPIOID MODULATION | 5 | 29% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
OPIOID ENDOCRINOPATHY | 2015 | 1 | 42 | 62% |
Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem | 2014 | 2 | 71 | 58% |
The Prevalence of Sexual Dysfunction among Male Patients on Methadone and Buprenorphine Treatments: A Meta-Analysis Study | 2014 | 3 | 32 | 41% |
The Impact of Opioids on the Endocrine System | 2009 | 61 | 46 | 48% |
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems | 2010 | 91 | 359 | 37% |
OPIOID MODULATION OF GONADOTROPIN AND PROLACTIN SECRETION IN DOMESTIC FARM-ANIMALS | 1991 | 44 | 81 | 79% |
EFFECTS OF OPIOIDS ON THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS | 1993 | 67 | 99 | 67% |
Opioid-Induced Androgen Deficiency (OPIAD) | 2012 | 11 | 47 | 34% |
MANDATORY NEUROPEPTIDE-STEROID SIGNALING FOR THE PREOVULATORY LUTEINIZING-HORMONE-RELEASING HORMONE DISCHARGE | 1993 | 333 | 283 | 15% |
NEURAL REGULATION OF LUTEINIZING-HORMONE SECRETION IN THE RAT | 1983 | 673 | 149 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT CANC PAIN MANAGEMENT | 3 | 100% | 0.2% | 3 |
2 | AGR FO TRY 310C | 2 | 67% | 0.1% | 2 |
3 | PHARM MED POLO PONTINO | 1 | 50% | 0.1% | 2 |
4 | UNIV LOS ALTOS | 1 | 18% | 0.3% | 5 |
5 | CLIN UNIT FAMILY MED | 1 | 33% | 0.1% | 2 |
6 | MED T002 REPROD MED | 1 | 23% | 0.2% | 3 |
7 | HUMANPHARMAKOL ZENTRUM | 1 | 50% | 0.1% | 1 |
8 | INPATIENT PAIN SERV | 1 | 50% | 0.1% | 1 |
9 | IST EMATOL ENDOCRINOL | 1 | 50% | 0.1% | 1 |
10 | MILANO MOL PHARMACOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000201850 | SEMINOL CLIN EMBRYOL//NALOXONE BINDING SITE//NURSERY 2 |
2 | 0.0000122624 | NUTRITIONAL INFERTILITY//REPROD SCI PROGRAM//METABOLIC FUELS |
3 | 0.0000120796 | TIDA NEURON//TUBEROINFUNDIBULAR DOPAMINE NEURONS//TUBEROINFUNDIBULAR NEURONS |
4 | 0.0000116150 | NANPAO//FEMALE REPRODUCTIVE AGING//GOMORI GLIA |
5 | 0.0000114115 | EA 4468GERIATR//EUROPEAN STUDY DIABET CEED//BETA ENDORPHIN LIKE IMMUNOREACTIVITY |
6 | 0.0000107636 | LHRH PULSE GENERATOR//N METHYL D//N METHYL D L ASPARTATE |
7 | 0.0000100394 | EXPERIMENTAL ORAL CANCER//ROMAN HIGH AVOIDANCE//ROMAN LOW AVOIDANCE |
8 | 0.0000097915 | FSH AND PMSG SUPEROVULATION//PINEAL N ACETYLTRANSFERASE ACTIVITY//EMINENTIA MEDIANA |
9 | 0.0000088711 | HYPOTHALAMIC AMENORRHEA//PULSATILE GNRH//INTERDISCIPLINARY BIOPHYS PROGRAM |
10 | 0.0000083098 | PROOPIOMELANOCORTIN//PROOPIOCORTIN//PROOPIOMELANOTROPIN |